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ABSTRACT 
Over the past few decades, tendency toward innovative drug delivery systems has almightily increased attempts to ensure efficacy, 
safety and patient acceptability. As discovery and development of new chemical agents is a complex, expensive and time consuming 
process, so recent trends are shifting toward designing and developing innovative drug delivery systems for existing drugs. Orally 
fast dissolving film is the kind of drug delivery system which when placed in the oral cavity, disintegrate or dissolve within a few 
seconds without the intake of water. Oral fast dissolving film is relatively new dosage form in which thin film is prepared using 
hydrophilic polymers, which rapidly disintegrate or dissolves on tongue or in the buccal cavity It is an alternative platform for 
molecules that undergoes high first pass metabolism. The method of preparation for oral dissolving film. Solvent casting, Semisolid 
casting, Hot melt extrusion, Solid dispersion extrusion, Rolling The current evaluation gives an account of different formulations 
methods of preparation and quality control of the fast dissolving oral thin film.  
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INTRODUCTION 
Orally fast-dissolving film is new drug delivery system for 
the oral delivery of the drugs. Almost 90% of the drugs are 
administered to the body via oral route for the treatment of 
various disorders and diseases as it is regarded as the 
safest, most convenient and most economical method of 
drug delivery and have the highest patient compliance. 1-4. 
The drug is either dissolved or swallowed, which then 
enters into the systemic circulation to produce the desired 
effect 5-6. Fast dissolving oral thin films is an ultra thin film 
that employs a hydrophilic polymer that rapidly hydrates 
or adheres when placed on the tongue or in the buccal 
cavity 7. These films disintegrate or dissolve within seconds 
to release the active agent without drinking and chewing 
8,9. The instant bioavailability results from bypassing first 
pass metabolism. So they are generally designed for the 
drugs having high first pass metabolism for achieving 
better bioavailability 10,11. 
Advantages12,13 
1. Easy transportation 
2. No need of water for administration 
3. Oral strip technology provides an alternate route for 
drugs with first pass metabolism14. 
4. Ease of administration of film to the patients suffering 
from dysphagia, repeated emesis, motion sickness, and 
mental disorders 
5. Large surface area provides rapid disintegration and 
dissolution in the oral cavity. 
Disadvantages 15 
1. Drugs which are unstable at buccal pH cannot be 
administered. 
2. Drugs with high dose cannot be incorporated into the 
film 
3. Drugs which irritate the mucosa cannot be administered 
by this route 
4. As it is fragile and must be protected from water, it 
requires special packaging. 
FORMULATION CONSIDERATION 
 Active pharmaceutical ingredient 
 Film forming polymers 
 Plasticizer 
 Sweetening agent 
 Saliva stimulating agent 
 Flavoring agent 
 Coloring agentNSIDERATION 
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Active pharmaceutical ingredient 
A typical formation of the film contains 1-25% w/w of the 
drug. Variety of active pharmaceutical ingredients can be 
delivered through fast dissolving films. Small dose 
molecules are the best candidates to be incorporated in 
oral fast dissolving films. Multivitamins up to 10% w/w of 
dry film weight was absorb in the films with dissolution 
time of less than 60 seconds. It is always useful to have 
micronized active pharmaceutical ingredients which will 
improve the texture of the film and also for better 
dissolution and uniformity in the oral fast dissolving films. 
Many active pharmaceutical ingredients, which are 
potential candidates for oral fast dissolving films 
technology, have bitter taste. This makes the formulation 
uneatable especially for pediatric preparations. Thus 
before incorporating the active pharmaceutical ingredients 
in the oral fast dissolving films, the taste needs to be 
masked. Various methods can be used to improve the 
edible of the formulation. Among the techniques employed, 
the simplest method involves the mixing and co-processing 
of bitter tasting active pharmaceutical ingredients with 
excipients with pleasurable taste. This is often termed as 
obscuration technique. 16-21.RMUL 
Film-Forming Polymers 
Polymers are the most important ingredient of the fast 
dissolving oral film. Robustness of the film depends on the 
quantity of polymer added in the oral strip. Generally, 45% 
w/w of polymer is used which is based on total weight of 
dry film. The selection of polymer is one of the most 
important and critical parameters for the successful 
development of oral films because of their tensile strength 
which depends upon the type and quantity of polymer used 
22. Mainly hydrophilic polymers are used in the oral strip as 
they rapidly disintegrate in the 
oral cavity as they come in contact with saliva 23. Currently, 
both natural & synthetic polymers are used for the 
preparation of fast dissolving film. 
Plasticizers 24-28 
It is an main ingredient of oral thin films. The plasticizers 
help to better the mechanical properties of film such as 
tensile strength and elongation to the film. It also 
minimizes the brittleness of the film. It may better the flow 
and enhances the strength of polymer. The proper 
selection of the plasticizers is very main. It should be 
compatible with the drug, polymers as well as with the 
other excipients. The irrerular selection may cause 
cracking, splitting and peeling of the film. The commonly 
used plasticizers are glycerol, propylene glycol, 
polyethylene glycol, dimethyl, dibutyl, diethyl phthalate, n- 
tributyl, triethyl, actyl citrate, triacetin and castor oil. 
Surfactants 29-30 
Surfactants are used as a wetting or solubilizing or 
dispersing agent so that the film is getting dissolved within 
seconds and release active agent immediately. Commonly 
employed are poloxamer 407, benzethonium chloride, 
sodium lauryl sulfate, tweens, benzalkonium chloride, etc. 
Out of these most predominantly used surfactants is 
poloxamer 407. 
Sweetening agents 31-32 
Sucrose is the most commonly used sweeteners in fast 
dissolving oral films. Sucrose is very soluble in water and 
being colorless does not impart any undesirable color to 
the final formulation. Some of the commonly employed 
sweeteners are dextrose, sucrose, fructose, glucose, 
isomaltose, polyhydric alcohols (sorbitol, mannitol), etc. 
Artificial sweeteners like saccharin, cyclamate, aspartame 
(first generation), sucralose, alitame and neotame (second 
generation) can also be used. 
Saliva stimulating agents 33 
Saliva stimulating agents are used to increase the rate of 
making of saliva that would help in the faster 
disintegration of the quick dissolving strip formulations. 
Examples of salivary stimulants  are citric acid, malic acid, 
lactic acid, ascorbic acid and tartaric acid. 
Flavouring agents 31 
Flavours used in the formulation must be non-toxic, 
soluble, stable and compatible with the excipients. The 
quantity of flavouring agent required to mask the taste 
depends on the flavor type and its strength. 
Colouring agents 34 
Generally incorporated colouring agents have FD&C 
approved colours, natural colours, pigments such as 
titanium dioxide etc. The colouring agents should not 
exceed concentration levels of 1%w/w. 
METHOD OF PREPARATION 35-37 
There are five methods which are used alone or in a 
combination with the following process for the 
manufacture of the fast dissolving oral films 
i) Solvent casting 
ii) Semisolid casting 
iii) Hot melt extrusion 
iv) Solid dispersion extrusion 
v) Rolling 
1. Solvent casting38-39 
Water soluble polymers and plasticizers are dissolved in a 
acceptable volatile solvent like Ethanol or distilled water to 
form a clear viscous solution. Solution is stirred for 2hrs in 
the magnetic stirrer and kept aside active pharmaceutical 
ingredient and other ingredients are dissolved in aqueous 
solvent and are combined with the bulk. The entrapped air 
is separate by vacuum Finally the solution is casted into a 
acceptable Petri dish and dried in an oven at 50 oC for 24 
hrs Film is cut into desired size and shape. 
2.  Semisolid casting38-39 
Solution of water soluble film forming polymer is prepared 
It is poured into the solution of acid insoluble polymers in 
the ratio of 1:4 .A gel mass is obtained by the incorporation 
of relevant quantity of plasticizer it is casted into the films 
or ribbons by using heat controlled drums. The diameter of 
the film should be about 0.015 - 0.05 inches. 
3.  Hot melt extrusion40 41 
In hot melt extrusion method essentially the drug is mixed 
with carrier in solid form. Then dried granular material is 
introduced into the extruder. The short speed should set at 
15 rpm in order to process the granules inside the barrel of 
the extruder for approximately 3 – 4 min. The processing 
temperatures should be 800C (zone 1), 1150C (zone 2), 
1000C (zone 3) and 650C (zone 4). The extrudate  (T = 
650C) then depressed  into a cylindrical calendar in order 
to obtain a film. There are certain comforts of hot melt 
extrusion 28, 29.  
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-Fewer operation units  
-Better content uniformity  
-An anhydrous process 
4.  Solid dispersion extrusion39-41 
In this method, the presence of amorphous hydrophilic 
polymers, one or more active ingredients are dispersed in 
an suspended carrier in a solid state. Active Pharmaceutical 
Ingredient  is dissolved in a suitable solvent to obtain a 
solution Solution is added into the melt of suitable polymer 
(PEG) below 70 °C without removing liquid solvent Finally 
by a means of dies, solid dispersion are form into films. 
5.  Rolling42-43 
Firstly a pre-mix is prepared by film forming polymers, 
polar solvent and other add on except a drug. Add required 
quantity of drug to the pre-mix. The drug is blended with 
pre-mix to obtain stable matrix. The mixture obtained is 
fed into the roller. Film is formed and carried off by 
support roller. Wet film is then dried utilized controlled 
bottom drying. Film is cut into desired size and shape. 
EVALUATION PARAMETERS 44-45 
1. Mechanical Properties- 
 Thickness test- Thickness specifies the dose 
perfection of drug in the film. It is measured by a 
micrometer screw gauge or calibrated digital Vernier 
calipers at five unlike strategic locations and the mean 
value is calculated which indicates the final thickness 
of the film. The width of the film should be in the range 
of 5 - 200 µm.  
 Dryness test- About eight stages of the film drying 
process have been identified and they are set‐to‐touch, 
dust‐free, tack‐free (surface dry), Dry‐to touch, 
dry‐hard, dry‐through (dry‐to‐handle), dry‐to‐recoat 
and dry print‐free. Although these tests are essentially 
used for paint films most of the studies can be change 
intricately to evaluate pharmaceutical OFDF. The 
details of estimation of these parameters can be 
checked elsewhere and are beyond the scope of this 
review. Tack is the determination with which the strip 
adheres to an accessory (a piece of paper) that has 
been pressed into contact with the strip. Instruments 
are also available for this study. 
 Tensile strength- Tensile strength is the highest 
stress applied to a point at which the strip specimen 
breaks. It is calculated by the applied load at break 
divided by the cross sectional area of the strip as Given  
in  the equation below: 
Tensile Strength =  
load of breakage/ strip thickness × strip width 
 Percent elongation- When stress is appeal, a strip 
sample stretches and this is mention to as strain. 
Strain is basically the deformation of strip split by 
original dimension of the sample. 
Generally elongation of strip increases as the plasticizer 
content    increases30. 
% Elongation = Increase in length ×100/original length 
 Young’s modulus- It is the estimate of film stiffness. It 
is found as balance of applied stress to the strain in the 
elastic deformation region. It is determined by the 
following formula: 
 
Young’s modulus =  
(Slope/strip thickness *cross head speed)/ 100 
It can also be written as: 
Young’s modulus = force at corresponding strain/ cross-
sectional area*corresponding strain 
  Hardness and brittleness are attributing of the films which 
are related with Young’s modulus and tensile strength. A 
hard and brittle film represents higher value of tensile 
strength and Young’s modulus with small elongation. 
 Tear resistance- Tear resistance of plastic film is a 
complex function of its ideal resistance to rupture. 
Basically very short rate of loading 51 mm (2 in)/min 
is employed and is designed to measure the force to 
begin tearing. The maximum force required to tear the 
specimen is recorded as the tear resistance value in 
Newton. 
 Folding endurance- Folding endurance is set by 
repeated folding of the strip at the same place till the 
strip breaks. The number of times the film is folded 
without breaking is evaluating as the folding 
endurance value. 
2. Transparency46-47 
The transparency of the films can be decide using a simple 
UV spectrophotometer. Cut the film samples into rectangles 
and placed on the inner side of the spectrophotometer cell. 
The direct transmittance of films at 600 nm. The 
transparency of the films was calculated as follows: 
                    Transparency = (logT600)/b = - €c 
Where T600 is the transmittance at 600 nm and b is the 
film thickness (mm) and c is concentration. 
3. Contact angle44-45 
It allows the information about wetting behavior, 
disintegration time and dissolution of oral film. This can be 
executing with the help of goniometer at room 
temperature. For this cause, double distilled water should 
be used. A dry film is taken and a drop of double distilled 
water is situating on surface of the dry film. Images of 
water droplet are taken by a convey of digital camera 
within 10 s of deposition. Digital pictures should be 
analysed by image J 1.28v software for angle 
determination. 
4. Scanning electron microscopy47-48 
Scanning electron microscopy is an prime method to study 
the surface morphology of the film between different 
excipients and drug. A film sample is taken and placed in 
sample holder and at ×1000 magnification and various 
photomicrographs were taken using the tungsten filament 
as source of electron. 
5. In vitro disintegration test47-48 
It is the time at which the film disintegrates when conduct 
in contact with water. This test is carried out by position 
the film in the phosphate buffer. United State 
Pharmacopoeia disintegration apparatus can be also used 
to study the disintegration time. The disintegration time 
should be in the range of 5 - 30 sec. 
6. In-vitro dissolution test47-48 
Amount of drug substance that proceeds into the solution 
per unit time under standard conditions of temp, solvent 
concentration and liquid/solid interface is called 
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dissolution. A standard paddle apparatus described in any 
of the pharmacopoeia can be used for dissolution testing. 
When paddle type dissolution apparatus is used, it’s 
difficult to perform dissolution study of oral film as they 
can float above the dissolution medium. Selection of the 
dissolution media depends on the sink conditions and the 
highest dose of drug. During dissolution study, the 
temperature of the medium should be maintained at 37 ± 
0.5 oC and rpm at 50. 
7. Stability studies49-51 
Stability testing of the prepared formulation is mainly 
ready to check whether it is a stable product or not. It is 
also used for the determination of effect of temperature 
and humidity on the stability of the drug for the actual 
storage, initially the formulation is wrapped in a butter 
paper followed by aluminum foil wrapping over it, then 
this is load in an aluminum pouch and heat sealed. 
Formulation should be stored at 45oC / 75 % RH for 3 
months. Through the time of stability studies, triplicate 
samples are taken at three sampling intervals i.e. 0, 1 and 3 
month and films should be evaluated for physical changes 
and drug content. 
 
Table 1: Comparison between Fast Dissolving Oral Films and Fast Dissolving Tablets 
Sr No. Fast Dissolving Oral Film Fast Dissolving Tablet 
1 It is a film It is a tablet 
2 Greater dissolution due to larger surface area Lesser dissolution due to less surface area 
3 Low dose can only be incorporated High dose can be incorporated 
4 More patient compliance Less patient compliance than films 
5 No risk of chocking It has a fear of chocking 
 
CONCLUSION 
Fast dissolving oral films have better patient compliance 
and may improve biopharmaceutical properties, improve 
efficacy and better safety, compared with conventional oral 
dosage forms. After the Fast Dissolving Tablets, the new 
products as Fast Dissolving Oral Fasts are intended for the 
application in the oral cavity and they are innovative and 
promising dosage form especially for use in elder patients. 
The development of fast dissolving drug products also 
provides an opportunity for a line extension in a 
marketplace, for a wide range of drugs (e.g. NSAIDS, 
antiulcer, antihistamine, Hypnotics & sedatives, 
antipsychotics, antiparkinsonism, antiemetic, antimigraine 
and antidepressants). In future, this system is most 
acceptable and prescribed due to its quick action i.e. within 
a minute. Because of increasing patient demand, the 
popularity of these dosage forms will expand the study in 
future.
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